REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB B-Link Pharma (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB B-Link Pharma Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB B-Link Pharma is an enterprise located in Lithuania, with the main office in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on January 11, 2013. There are currently 16 (2025) people employed by UAB B-Link Pharma. There was a net sales revenue drop of 14.04% reported in UAB B-Link Pharma’s latest financial highlights for 2024. UAB B-Link Pharma’s net profit margin decreased by 1.25% in 2024.

Headquarters
Mokslininku g. 6A
Vilnius; Vilnius county; Postal Code: LT-08412

Contact Details: Purchase the UAB B-Link Pharma report to view the information.

Website: http://www.bluepharma.lt

Basic Information
Total Employees:
Purchase the UAB B-Link Pharma report to view the information.
Registered Capital:
Purchase the UAB B-Link Pharma report to view the information.
Financial Auditors:
Purchase the UAB B-Link Pharma report to view the information.
Incorporation Date:
January 11, 2013
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB B-Link Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-14.04%
Total operating revenue
-14.04%
Net Profit (Loss) for the Period
-51.47%
Total Equity
6.09%
Net Profit Margin
-1.25%
Return on Equity (ROE)
-9.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?